Latest

Schizophrenia

Electrophysiology Featured Neuroscience Psychology

·April 24, 2021·6 min read

The Immune Link Between a Leaky Blood-Brain Barrier and Schizophrenia

People with schizophrenia and other neuropsychiatric disorders may have a more permissive blood-brain barrier which allows the immune system to become more actively involved in the central nervous system. The resulting inflammation may contribute to the clinical manifestation of psychosis-like symptoms.

Featured Neuroscience Open Neuroscience Articles Psychology

·April 19, 2021·5 min read

Betaine Supplement Treats Schizophrenia in Mice

Betaine, a dietary supplement extracted from sweet beets, reduces behavioral symptoms of schizophrenia in mice with genetic risk factors for the disorder. The supplement may help protect proteins that build the cellular skeletons of neurons.

Featured Genetics Neuroscience Open Neuroscience Articles Psychology

·April 14, 2021·4 min read

Genetic Predisposition to Schizophrenia May Increase Risk of Psychosis From Cannabis Use

While cannabis users reported more psychotic experiences than non-users generally, the effect was more pronounced in those with a genetic risk factor for schizophrenia.

This is a drawing of a mouse against a psychedelic background

Featured Neuroscience Psychology

·April 1, 2021·5 min read

Mice With Hallucination-Like Behaviors Reveal Insight Into Psychotic Illness

Mouse study reveals elevated dopamine levels preceded hallucination-like events, and artificially boosting dopamine levels induced more hallucination-like events. The behavioral effects could be blocked by administering haloperidol, an antipsychotic which blocks dopamine. The study sheds light on potential new treatments for psychotic disorders marked by hallucinations.

Electrophysiology Featured Genetics Neuroscience Psychology

·March 27, 2021·7 min read

Gene Changes Linked to Severe Repetitive Behaviors

Study identifies genes that become activated in the brain prior to the initiation of severe repetitive behaviors associated with addiction, ASD, and schizophrenia.

This shows a blue question mark in a dark forest

Featured Neuroscience Psychology

·March 27, 2021·3 min read

Many QAnon Followers Report Having Mental Health Diagnoses

Research has long revealed an association between belief in conspiracy theories and mental health disorders. A new study reports followers of the radical QAnon group are significantly more likely to suffer from mental health problems, including depression, anxiety, and schizophrenia, than the general population.

Featured Neuroscience Psychology

·March 24, 2021·4 min read

DHA Supplement May Offset Impact of Maternal Stress on Unborn Males

DHA supplements have long been recommended for pregnant women to assist in healthy fetal development. A new study finds DHA supplements can also reverse the impact of early prenatal stress on developing male babies.

Featured Genetics Neuroscience Psychology

·March 23, 2021·5 min read

Large-Scale Genome Analysis Identifies Differences by Sex in Major Psychiatric Disorders

Researchers found that while there are genetic overlaps between the sexes in relation to mental health disorders, there are also sex-specific differences in how genes related to the immune system, central nervous system, and blood vessels affect people with mental health problems.

This shows a woman covering her face with her hands

Featured Open Neuroscience Articles Psychology

·March 19, 2021·4 min read

Disability Highest for Schizophrenia and Personality Disorders

Study reveals personality disorders and schizophrenia are the most debilitating mental illnesses to live with.

This shows a hand holding an e cigarette

Featured Psychology

·March 17, 2021·4 min read

Electronic Cigarettes Help Smokers With Schizophrenia Quit

Between 60-90% of people with schizophrenia smoke, compared to between 15-24% of the general population. A new study found 40% of those with schizophrenia stopped smoking traditional cigarettes after 12 weeks of switching to e-cigarettes. Researchers also reported a significant number of participants sustained their reduction in smoking or completely stopped smoking at the end of the 12-week study.